Search research articles
Contact Us
Filters
Showing results (41-50 of 101) with videos related to
Page
of 11
Sort By:
Journal of Geriatric Psychiatry and Neurology
|
May 13, 2006
Patterns of initial pharmacotherapy for Parkinson's disease in the United States
Daniel M Huse, Jane Castelli-Haley, Lucinda S Orsini, et al.
The American Journal of Cardiology
|
May 30, 1998
Direct medical costs of coronary artery disease in the United States
M W Russell, D M Huse, S Drowns, et al.
Medical Care
|
May 1, 1996
The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum")
G Oster, T E Delea, D M Huse, et al.
Medical Care
|
September 1, 1990
The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers
G Oster, D M Huse, T E Delea, et al.
Molecular Cell
|
October 5, 2001
The TGF beta receptor activation process: an inhibitor- to substrate-binding switch
M Huse, T W Muir, L Xu, et al.
The Annals of Pharmacotherapy
|
May 1, 1995
Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis
G Oster, D M Huse, M J Lacey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2005
Burden of illness in Parkinson's disease
Daniel M Huse, Kathy Schulman, Lucinda Orsini, et al.
The American Journal of Medicine
|
September 1, 1989
Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy
J M Richter, G A Colditz, D M Huse, et al.
JAMA
|
November 17, 1989
The economic costs of non-insulin-dependent diabetes mellitus
D M Huse, G Oster, A R Killen, et al.
Plos One
|
March 24, 2015
Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model
Camelia M Saffarini, Elizabeth V McDonnell-Clark, Ali Amin, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 101) with videos related to
Sort By:
Page
of 11
Journal of Geriatric Psychiatry and Neurology
|
May 13, 2006
Patterns of initial pharmacotherapy for Parkinson's disease in the United States
Daniel M Huse, Jane Castelli-Haley, Lucinda S Orsini, et al.
The American Journal of Cardiology
|
May 30, 1998
Direct medical costs of coronary artery disease in the United States
M W Russell, D M Huse, S Drowns, et al.
Medical Care
|
May 1, 1996
The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum")
G Oster, T E Delea, D M Huse, et al.
Medical Care
|
September 1, 1990
The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers
G Oster, D M Huse, T E Delea, et al.
Molecular Cell
|
October 5, 2001
The TGF beta receptor activation process: an inhibitor- to substrate-binding switch
M Huse, T W Muir, L Xu, et al.
The Annals of Pharmacotherapy
|
May 1, 1995
Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis
G Oster, D M Huse, M J Lacey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2005
Burden of illness in Parkinson's disease
Daniel M Huse, Kathy Schulman, Lucinda Orsini, et al.
The American Journal of Medicine
|
September 1, 1989
Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy
J M Richter, G A Colditz, D M Huse, et al.
JAMA
|
November 17, 1989
The economic costs of non-insulin-dependent diabetes mellitus
D M Huse, G Oster, A R Killen, et al.
Plos One
|
March 24, 2015
Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model
Camelia M Saffarini, Elizabeth V McDonnell-Clark, Ali Amin, et al.
Page
of 11